About Chiral Technologies
Chiral Technologies is a Healthcare company based in West Chester (United States) founded in 1990. Advanced chirality products and custom purification services. The company has 368 employees. Chiral Technologies has completed 2 acquisitions, including Arbor Biosciences and Diffinity Genomics. Its Indian entity Daicel Chiral Technologies (India) Private Limited reported revenue of ₹162 Cr. Chiral Technologies offers products and services including Chiral Selectors, HPLC/UHPLC, Preparative Chromatography, and Technical Support. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its competitors include ChromaTan, Sepax Technologies and Semba Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Chiral Technologies, a subsidiary of Daicel Corp, develops systems for enantioselective chromatography and has the most extensive portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. Additionally, the company also supplies bulk chiral stationary phases and operates an outsourcing center for separation of chiral intermediates and APIs in pre-clinical and clinical evaluations.
- Headquarters West Chester, United States
- Employees 368
- SectorsHealthcare
- Phone•••• ••••
- Website chiraltech.com
- Social LinkedIn X
- Legal Name Daicel Chiral Technologies (India) Private Limited
- Date of Incorporation 02 Apr, 2008
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹162 Cr
FY 2025 · +30% YoY
- Indian entity net profit₹6.82 Cr
FY 2025 · 4% margin
- Indian entity EBITDA₹27.02 Cr
FY 2025 · 17% margin
- Employee Count368
- Investments & AcquisitionsArbor Biosciences
& 1 more
Associated legal entities of Chiral Technologies
Chiral Technologies operates through Daicel Chiral Technologies (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daicel Chiral Technologies (India) Private Limited CIN U24100TG2008PTC058509 | Active | 02 Apr 2008 | Hyderabad, Telangana | ₹162 Cr | 368 | 5 | View details |
Products & Services of Chiral Technologies
Chiral Technologies offers a comprehensive portfolio of products and services, including Chiral Selectors, HPLC/UHPLC, Preparative Chromatography, and Technical Support.
Products for optical isomer separation in pharmaceuticals and research.
Methods for high-performance liquid chromatography in life sciences.
Services for large-scale enantiomer separation projects.
Assistance for column selection and method development in separations.
Board of directors of Daicel Chiral Technologies (India) Private Limited (Chiral Technologies)
Daicel Chiral Technologies (India) Private Limited is the primary company behind Chiral Technologies. The board of Daicel Chiral Technologies (India) Private Limited currently have 5 directors; the longest-serving is Lakshmi Narayana Chennuru, appointed in 2012. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lakshmi Narayana Chennuru DIN 05314602 | Managing Director | 27 Jun 2012 | 14 yrs 4 mo | Daicel Chiral Technologies (India) Private Limited |
| Tatsushi Murakami DIN 07562247 | Director | 20 Jul 2016 | 10 yrs 3 mo | Daicel Chiral Technologies (India) Private Limited |
| Seiji Sakano DIN 09637449 | Director | 15 Jun 2022 | 4 yrs 4 mo | Daicel Chiral Technologies (India) Private Limited |
| Kenichiro Miyazawa DIN 11096790 | Director | 13 May 2025 | 1 yr 5 mo | Daicel Chiral Technologies (India) Private Limited |
| Hideaki Yamamoto DIN 11097554 | Director | 13 May 2025 | 1 yr 5 mo | Daicel Chiral Technologies (India) Private Limited |
Financials of Chiral Technologies
Figures of Daicel Chiral Technologies (India) Private Limited, the primary company behind Chiral Technologies, for FY 2025. Revenue was ₹162 Cr (+30% year on year). Net profit was ₹6.82 Cr (4% margin). EBITDA was ₹27.02 Cr (17% margin). Revenue has grown at a compounded annual rate of +10% over three years and +21% over five years.
- ₹162 CrRevenue · FY 2025 · +30% YoY
- ₹6.82 CrNet profit · 4% margin
- ₹27.02 CrEBITDA · 17% margin
- ₹44 LakhPaid-up capital
- 368Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daicel Chiral Technologies (India) Private Limited are on its company page.
Detailed financial statements for Chiral Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chiral Technologies
Chiral Technologies has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Arbor Biosciences and Diffinity Genomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DNA analysis microarrays are provided by Arbor Biosciences. | arborbiosci.com | Detroit, United States | 2006 | Jan 2019 | •••• | |
Genomics technologies are developed by Diffinity Genomics since 2005. | diffinitygenomics.com | West Henrietta, United States | 2005 | Aug 2015 | •••• |
Complete acquisition details for Chiral Technologies
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Chiral Technologies
3 dated milestones of Chiral Technologies across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Chiral Technologies is founded.
- Acquisition Acquires Diffinity Genomics.
- Acquisition Acquires Arbor Biosciences.
Competitors of Chiral Technologies
Chiral Technologies has 3 listed competitors in our database, 3 of them funded. They include ChromaTan, Sepax Technologies and Semba Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | Continuous countercurrent tangential chromatography separation technology is developed. | ||
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) |
Detailed competitors of Chiral Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Chiral Technologies
The website of Chiral Technologies (chiraltech.com) receives about 5.2K visits a month.
- Monthly visits5.2K
▼ 13.1% vs previous month
Websites whose visitors overlap most with Chiral Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| daicelchiral.com | 100% | #1,359,659 | View details | ||
hplc.eu | hplc.eu | 93% | – | ||
elementlabsolutions.com | elementlabsolutions.com | 76% | #853,636 | – | |
| sielc.com | 73% | 41.8K | #822,744 | View details | |
jkscientific.com | jkscientific.com | 72% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Chiral Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Chiral Technologies (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chiral Technologies
Complete news archive for Chiral Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiral Technologies
Chiral Technologies was founded in 1990.
Chiral Technologies is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.
Chiral Technologies has 368 employees.
The primary company behind Chiral Technologies, Daicel Chiral Technologies (India) Private Limited, reported revenue of ₹162 Cr for FY 2025, up 30% year on year.
Chiral Technologies, a subsidiary of Daicel Corp, develops systems for enantioselective chromatography and has the most extensive portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. Additionally, the company also supplies bulk chiral stationary phases and operates an outsourcing center for separation of chiral intermediates and APIs in pre-clinical and clinical evaluations.
Chiral Technologies's top competitors include ChromaTan, Sepax Technologies and Semba Biosciences.
Chiral Technologies offers Chiral Selectors, HPLC/UHPLC, Preparative Chromatography, and Technical Support.
Chiral Technologies has made 2 acquisitions, including Arbor Biosciences, and Diffinity Genomics.
Chiral Technologies operates through Daicel Chiral Technologies (India) Private Limited.
The legal entities of Chiral Technologies currently have 5 directors, including Seiji Sakano, Lakshmi Narayana Chennuru, Tatsushi Murakami and others.